Pfizer (PFE) R&D to Revenue & History | Stock Alarm

Demo Sign up Log In

Pfizer · R&D to Revenue

PFE R&D to Revenue

Latest reported19.14%period endingDec 31, 2025

PFE FY R&D/Revenue (0.00% → 19.14%)

Latest values, visible window

High-resolution chart · PNG

PFE r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer R&D to Revenue — Annual fiscal periods
Period ending	R&D to Revenue
Dec 31, 2025	19.1374%
Dec 31, 2024	16.8765%
Dec 31, 2023	17.7623%
Dec 31, 2022	11.3884%
Dec 31, 2021	17.0111%
Dec 31, 2020	22.5565%
Dec 31, 2019	20.3148%
Dec 31, 2018	14.8508%
Dec 31, 2017	14.5492%
Dec 31, 2016	14.8417%
Dec 31, 2015	15.7029%
Dec 31, 2014	16.7523%
Dec 31, 2013	12.6997%
Dec 31, 2012	12.7248%
Dec 31, 2011	13.1138%
Dec 31, 2010	13.9553%
Dec 31, 2009	15.5052%
Dec 31, 2008	15.5541%
Dec 31, 2007	15.6376%
Dec 31, 2006	15.346%
Dec 31, 2005	15.2009%
Dec 31, 2004	14.5099%
Dec 31, 2003	15.7807%
Dec 31, 2002	15.9886%
Dec 31, 2001	15.0253%
Dec 31, 2000	14.9963%
Dec 31, 1999	17.1316%
Dec 31, 1998	16.8266%
Dec 31, 1997	15.4191%
Dec 31, 1996	0%
Dec 31, 1995	0%
Dec 31, 1994	0%
Dec 31, 1993	0%
Dec 31, 1992	0%
Dec 31, 1991	0%
Dec 31, 1990	0%
Dec 31, 1989	0%
Dec 31, 1988	0%
Dec 31, 1987	0%
Dec 31, 1986	0%
Dec 31, 1985	0%

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.